First‐Line Immune‐Combination Therapy for Driver Gene‐Negative NSCLC With Brain Metastases: Real‐World Outcomes

First‐Line Immune‐Combination Therapy for Driver Gene‐Negative NSCLC With Brain Metastases: Real‐World Outcomes

ABSTRACT Background Optimal treatment for driver gene‐negative non‐small cell lung cancer (NSCLC) with brain metastases (BM) remains unclear, particularly regarding immune checkpoint inhibitor (ICI)‐based combinations and local BM therapy. Predictive biomarkers for intracranial efficacy are also und...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengxing You, Lige Wu, Jiayu Liu, Hanqi Yuan, Zihe Wang, Xuezhi Hao, Puyuan Xing, Junling Li
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Thoracic Cancer
Subjects:
brain metastases
driver gene
immunotherapy
non‐small cell lung cancer
real‐world study
Online Access:https://doi.org/10.1111/1759-7714.70095
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/1759-7714.70095

Similar Items